Life Science Leader Magazine Supplements

CRO Supplement 2015

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/503574

Contents of this Issue

Navigation

Page 14 of 51

15 LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2015 panies become more engaged with patients and recognize them as key stakeholders in the design process, mobile health technology will impact patients not only during the trial but before the protocol is even designed. For example, our partnership with StoryVine to create the Patient Experience via a mobile app has led to capturing insights from patients, in their own words, regarding potential study designs and eliciting their feedback regarding potential hurdles to patient-centricity that might prevent them from joining a study or cause them to drop out at a later date. The Patient Experience provides researchers with a way to see and hear patients who may be halfway around the world, sitting in their own home. At the same time, patients are empowered by this technology. The firsthand input provided by people who are living with disease is having a measurable impact on study design, which ultimately benefits patient recruitment and retention programs. BORBAS: eRecruiting methods include Web, mobile, and social media. We are moving toward these methods as a primary source of information. Websites are also a good way to interact with patients. We are seeing an increased demand for speed and targeted enrollment of the best patients. These methods will better meet those demands than more traditional methods. DAVIS: The clinical research industry is increasingly adopt- ing a more patient-centric approach that recognizes that if patients are supported throughout a study, higher levels of compliance and retention can be achieved. Listening to the patient during drug development and partnering throughout their clinical trial experience, as well as the simplification of methods to capture and report patient data obtained during the trial, is now seen as vital to pharmaceutical R&D success. Sponsors and CROs have demonstrated a growing desire to simplify clinical data collection by implementing innovative solutions that provide greater access (in real time) to better quality data, in a more cost-effective way — while in parallel helping to facilitate continuous patient engagement for the duration of the study. A recent study seemed to show that recruitment via texting may have significant advantages over email. Are there any downsides, and do you expect the use of texting to increase in the future? BORBAS: I think that despite the impersonal nature of tex- ting, people seem to be comfortable with it, and it is a good way to communicate. You have some limitations with texting Visit eClinicalOS.com eClinicalOS cloud-based clinical software solutions to streamline clinical research. Data management with efciency, productivity, communication, and collaboration. eClinicalOS is a solution of Merge Healthcare Incorporated. © 2015 All rights reserved. 866.387.4257 | eClinicalOS.com Have Trials Take Flight

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Supplement 2015